592554-79-5

Usage

Explanation

The compound consists of 7 carbon atoms, 10 hydrogen atoms, 4 nitrogen atoms, and 1 oxygen atom.
2. Derivative of imidazole

Explanation

It is a modified version of the imidazole molecule, which is a heterocyclic aromatic organic compound.

Explanation

This is the commonly used name for 1H-Imidazole-5-carboxamide, N-methoxy-N,1-dimethyl-.
4. Use in synthesis of pharmaceuticals and agrochemicals

Explanation

The compound serves as a building block or intermediate in the production of various drugs and pesticides.
5. Production of organic compounds

Explanation

It is used as a reactant or starting material in the synthesis of a variety of organic compounds.
6. Building block in organic chemistry

Explanation

Due to its chemical properties, the compound is a valuable component in creating a wide range of products in the field of organic chemistry.
7. Versatile chemical properties

Explanation

The properties of 1H-Imidazole-5-carboxamide, N-methoxy-N,1-dimethylallow it to be used in numerous chemical reactions and processes, making it a valuable compound in various applications.

Upstream product

• 41806-40-0 1-methyl-1H-imidazole-5-carboxylic acid 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 20970-50-7 1-(3-methyl-3H-imidazol-4-yl)-ethanone 
• 1450738-61-0 (3,4-dichlorophenyl)-(3-methyl-3H-imidazol-4-yl)methanone 
• 1450738-62-1 (4-methoxyphenyl)-(3-methyl-3H-imidazol-4-yl)methanone 
• 1599530-93-4 (3-(4-(1H-pyrazol-1-yl)benzyl)-4-chloro-2-methoxy-8-methylquinolin-6-yl)bis(1-methyl-1H-imidazol-5-yl)methanol 

Relevant academic research and scientific papers

METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt

The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T

The present invention comprises compounds of Formula (I). wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt

The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.

NEW IMIDAZOLYLKETONE DERIVATIVES

The invention provides novel compounds having the general formula (I) wherein R1, R2, R3 and R4 n are as described herein, compositions including the compounds and methods of using the compounds.

IMIDAZOLYLKETONE DERIVATIVES ASD ALDOSTERONE SYNTHASE INHIBITORS

The invention provides novel compounds having the general formula (I), wherein R1, R2, R3 and R4 n are as described herein, compositions including the compounds and methods of using the compounds as inhibitors of aldosterone synthase.

Novel farnesyl protein transferase inhibitors as antitumor agents

Disclosed are novel tricyclic compounds represented by the formula (1.0): and a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising compounds of formula 1.0. Also disclosed are methods of treating cancer using the compounds of formula 1.0.